Na Young Yi
Overview
Explore the profile of Na Young Yi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhagat H, Compton S, Musso D, Laudeman C, Jackson K, Yi N, et al.
PLoS One
. 2018 Oct;
13(10):e0204605.
PMID: 30359371
Obesity and insulin resistance are primary risk factors for Non-Alcoholic Fatty Liver Disease (NAFLD). NAFLD is generally exhibited by non-progressive simple steatosis. However, a significant subset of patient's progress to...
2.
Sung E, Ryuda M, Matsumoto H, Uryu O, Ochiai M, Cook M, et al.
Proc Natl Acad Sci U S A
. 2017 Dec;
114(52):13786-13791.
PMID: 29229844
A systems-level understanding of cytokine-mediated, intertissue signaling is one of the keys to developing fundamental insight into the links between aging and inflammation. Here, we employed , a routine model...
3.
Yi N, He Q, Caligan T, Smith G, Forsberg L, Brenman J, et al.
Assay Drug Dev Technol
. 2015 Oct;
13(9):558-69.
PMID: 26505612
Diabetes currently affects 9.3% of the U.S. population totaling $245 billion annually in U.S. direct and indirect healthcare costs. Current therapies for diabetes are limited in their ability to control...
4.
Yi N, Newman D, Zhang H, Morales Johansson H, Sannes P
Exp Lung Res
. 2015 Oct;
41(9):499-513.
PMID: 26495958
Purpose/aim: Previous studies have indicated that the sulfated polysaccharide heparin has anti-inflammatory effects. However, the mechanistic basis for these effects has not been fully elucidated. Materials And Methods: NCI-H292 (mucoepidermoid)...
5.
Davis J, Yi N, Salmon J, Charlton A, Colitz C, Gilger B
J Ocul Pharmacol Ther
. 2012 Mar;
28(4):359-68.
PMID: 22372691
Purpose: To determine whether celecoxib (CXB) can be released from incubated intraocular lenses (IOLs) sufficiently to inhibit lens epithelial cell (LEC) growth in an ex vivo model of posterior capsule...
6.
Park S, Yi N, Jeong M, Kim W, Kim S, Chae J, et al.
Vet Ophthalmol
. 2009 Jul;
12(4):205-10.
PMID: 19604334
Objective: To determine the incidence, etiology, and concurrent ophthalmic findings in small breed dogs that presented with cataracts. Animal Studied: Five hundred and sixty-one small breed dogs (942 eyes) were...
7.
Yi N, Park S, Jeong M, Kim W, Kim S, Kim J, et al.
Vet Ophthalmol
. 2009 Apr;
12(3):139-51.
PMID: 19392873
Objective: To evaluate motility of silicone orbital implants and corneoscleral prostheses, with and without use of a motility coupling post (MCP) in dogs. Animals Studied: Eighteen mixed-breed dogs. Procedures: The...
8.
Yi N, Park S, Jeong M, Kim M, Lim J, Nam T, et al.
J Am Anim Hosp Assoc
. 2006 Nov;
42(6):435-9.
PMID: 17088390
The medical records of 23 dogs that underwent medial canthoplasty for treatment of epiphora were reviewed. The most prevalent breed encountered was the shih tzu. Other affected breeds included the...
9.
Yi N, Park S, Jeong M, Kim W, Kim S, Chae J, et al.
J Vet Sci
. 2006 Jul;
7(3):281-5.
PMID: 16871024
This study evaluated the surgical outcome and complications of phacoemulsification and the implantation of an acryl foldable intraocular lens (IOL) with a squared edge in dogs with cataracts. Thirty-two eyes...
10.
Park S, Jeong S, Yi N, Kim M, Jeong M, Suh J, et al.
Exp Anim
. 2006 May;
55(2):83-90.
PMID: 16651690
In pharmaceutical companies and research institutes, many toxicity tests are performed with laboratory animals. This study was performed to produce reference data for eye toxicity tests and to investigate the...